###begin article-title 0
Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose
###end article-title 0
###begin p 1
These authors contributed equally to this work
###end p 1
###begin p 2
Present address: Microbiology and Infection Research Domain, Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
###end p 2
###begin p 3
This document may be redistributed and reused, subject to .
###end p 3
###begin title 4
Summary
###end title 4
###begin p 5
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 880 885 872 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-maf</italic>
CD4+ T cells producing interleukin-10 (IL-10) and interferon-gamma (IFN-gamma) are reported in chronic infections. However, the signals that direct the development of IL-10-producing T helper 1 (Th1) cells are undefined. We showed that development of IL-10-producing Th1 cells required high T cell receptor (TCR) ligation, sustained ERK1 and ERK2 MAP kinases phosphorylation, and IL-12-induced STAT4 transcription factor activation. Repeated TCR triggering led to enhanced IL-10 production by Th1 cells, and continued IL-12 action and high-dose TCR signaling were required for the development and maintenance of IL-10-producing Th1 cells. Although Th1, Th2, and Th17 cells require the activation of distinct STATs for their differentiation, activation of ERK1 and ERK2 was a common requirement for production of IL-10 by all Th cell subsets. IL-10 expression also correlated with c-maf expression. Despite having distinct functions in protection against pathogens, all Th cells share the important task of controlling overexuberant immune responses by means of IL-10 production.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 136 154 136 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35" ref-type="bibr">Moore et&#160;al., 2001</xref>
###xml 268 312 268 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35 bib38" ref-type="bibr">Moore et&#160;al., 2001; O'Garra and Vieira, 2004</xref>
###xml 370 431 370 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9 bib15 bib35" ref-type="bibr">Brooks et&#160;al., 2006; Ejrnaes et&#160;al., 2006; Moore et&#160;al., 2001</xref>
###xml 511 529 511 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35" ref-type="bibr">Moore et&#160;al., 2001</xref>
###xml 555 695 555 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib3 bib14 bib18 bib27 bib41" ref-type="bibr">Anderson et&#160;al., 2007; Assenmacher et&#160;al., 1994; Del Prete et&#160;al., 1993; Gerosa et&#160;al., 1996; Jankovic et&#160;al., 2007; Pohl-Koppe et&#160;al., 1998</xref>
###xml 714 756 714 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39 bib50" ref-type="bibr">O'Garra and Vieira, 2007; Trinchieri, 2007</xref>
###xml 794 862 794 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35 bib38 bib42" ref-type="bibr">Moore et&#160;al., 2001; O'Garra and Vieira, 2004; Roncarolo et&#160;al., 2006</xref>
###xml 881 973 881 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4 bib16 bib32 bib48" ref-type="bibr">Awasthi et&#160;al., 2007; Fitzgerald et&#160;al., 2007; McGeachy et&#160;al., 2007; Stumhofer et&#160;al., 2007</xref>
Interleukin-10 (IL-10) is a cytokine with broad anti-inflammatory properties that inhibits macrophage and dendritic cell (DC) function (Moore et al., 2001). IL-10 limits the immune and inflammatory responses to pathogens and gut flora and prevents damage to the host (Moore et al., 2001; O'Garra and Vieira, 2004), but when dysregulated may result in chronic infection (Brooks et al., 2006; Ejrnaes et al., 2006; Moore et al., 2001). IL-10 is expressed by T helper 2 (Th2) cells, B cells, DCs, and macrophages (Moore et al., 2001), and also by Th1 cells (Anderson et al., 2007; Assenmacher et al., 1994; Del Prete et al., 1993; Gerosa et al., 1996; Jankovic et al., 2007; Pohl-Koppe et al., 1998) and (reviewed in O'Garra and Vieira, 2007; Trinchieri, 2007), certain regulatory (Treg) T cells (Moore et al., 2001; O'Garra and Vieira, 2004; Roncarolo et al., 2006), and Th17 cells (Awasthi et al., 2007; Fitzgerald et al., 2007; McGeachy et al., 2007; Stumhofer et al., 2007).
###end p 7
###begin p 8
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 209 316 201 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib18 bib29 bib33 bib54" ref-type="bibr">Chang et&#160;al., 2007; Gerosa et&#160;al., 1996; Jeannin et&#160;al., 1996; Meyaard et&#160;al., 1996; Windhagen et&#160;al., 1996</xref>
###xml 481 500 469 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">Gerosa et&#160;al., 1999</xref>
###xml 576 593 564 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Toxoplasma gondii</italic>
###xml 595 635 583 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28 bib45" ref-type="bibr">Jankovic et&#160;al., 2002; Shaw et&#160;al., 2006</xref>
###xml 645 661 633 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania major</italic>
###xml 663 684 651 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">Anderson et&#160;al., 2007</xref>
###xml 770 814 758 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib27" ref-type="bibr">Anderson et&#160;al., 2007; Jankovic et&#160;al., 2007</xref>
###xml 976 1012 960 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35 bib50" ref-type="bibr">Moore et&#160;al., 2001; Trinchieri, 2007</xref>
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
###xml 471 479 <span type="species:ncbi:9606">patients</span>
###xml 576 593 <span type="species:ncbi:5811">Toxoplasma gondii</span>
###xml 645 661 <span type="species:ncbi:5664">Leishmania major</span>
In vitro human CD4+ and CD8+ T cell clones, or mouse CD4+ T cells that produce both interferon-gamma (IFN-gamma) and IL-10, can be differentiated by T cell receptor (TCR)-stimulation in the presence of IL-12 (Chang et al., 2007; Gerosa et al., 1996; Jeannin et al., 1996; Meyaard et al., 1996; Windhagen et al., 1996). Furthermore, Th1 cell clones coproducing IFN-gamma and IL-10 have been isolated from bronchoalveolar lavage (BAL) of active pulmonary tuberculosis (TB) patients (Gerosa et al., 1999). IL-10 production by Th1 cells was also reported in animals infected with Toxoplasma gondii (Jankovic et al., 2002; Shaw et al., 2006) or with Leishmania major (Anderson et al., 2007) and shown to be required for regulation of the immune response in these infections (Anderson et al., 2007; Jankovic et al., 2007). The relative amounts of IL-10 and IFN-gamma produced by Th1 cells may influence the balance between clearance and persistent infection with certain pathogens (Moore et al., 2001; Trinchieri, 2007), thus determining whether chronic infection or immunopathology ensues.
###end p 8
###begin p 9
###xml 83 160 83 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19 bib26 bib47" ref-type="bibr">Glimcher and Murphy, 2000; Ivanov et&#160;al., 2007; Stockinger and Veldhoen, 2007</xref>
###xml 539 564 527 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">Glimcher and Murphy, 2000</xref>
###xml 713 738 701 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">Glimcher and Murphy, 2000</xref>
###xml 870 920 851 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib26 bib47" ref-type="bibr">Ivanov et&#160;al., 2007; Stockinger and Veldhoen, 2007</xref>
Th1, Th2, and Th17 cell responses differentiate along distinct signaling pathways (Glimcher and Murphy, 2000; Ivanov et al., 2007; Stockinger and Veldhoen, 2007). Th1 cell development requires signal transducer and activator of transcription (STAT)1 activation, induced by type I IFN or IFN-gamma, the transcription factor T-box 21 (T-bet), and IL-12-induced STAT4 signaling, which can couple with IL-18-induced IRAK and NF-kappaB transcription factors to drive the high amounts of IFN-gamma required to eradicate intracellular pathogens (Glimcher and Murphy, 2000). Th2 cell development, with expression of IL-4, IL-5, and IL-13, requires IL-4, STAT6, and the transcription factor GATA binding protein (GATA)-3 (Glimcher and Murphy, 2000). The development of Th17 cells requires IL-6, TGF-beta, and the STAT3-dependent expression of the transcription factor RORgammat (Ivanov et al., 2007; Stockinger and Veldhoen, 2007).
###end p 9
###begin p 10
###xml 483 570 479 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13 bib23 bib30 bib56" ref-type="bibr">Constant et&#160;al., 1995; Hosken et&#160;al., 1995; Jorritsma et&#160;al., 2003; Yamane et&#160;al., 2005</xref>
Th1 and Th2 cell responses can also be induced by varying the dose of antigen presented to the naive T cell by the antigen-presenting cell (APC). Whereas high doses of antigen, with sustained TCR signaling and extracellular-signal regulated (ERK) mitogen-activated protein kinase (MAPK) phosphorylation, result in Th1 cells producing IFN-gamma via an IL-12-independent mechanism, low doses of antigen, with transient ERK1 and ERK2 activation, favor Th2 responses and IL-4 secretion (Constant et al., 1995; Hosken et al., 1995; Jorritsma et al., 2003; Yamane et al., 2005).
###end p 10
###begin p 11
###xml 174 230 174 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19 bib47" ref-type="bibr">Glimcher and Murphy, 2000; Stockinger and Veldhoen, 2007</xref>
Because Th1 and Th2 cells cross regulate each other's development and function and can suppress Th17 cell responses, and all differentiate along distinct signaling pathways (Glimcher and Murphy, 2000; Stockinger and Veldhoen, 2007), IL-10 produced by all these Th cells may thus act as a feedback regulator to control the pathology associated with an overexuberant, albeit efficacious, inflammatory response. Whether IL-10 production by these different Th cell subsets is induced by independent and/or common mechanisms is unknown.
###end p 11
###begin p 12
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Here, we showed that in vitro differentiation of IL-10-producing Th1 cells from naive CD4+ T cells required IL-12-induced STAT4 signaling, strong TCR activation (high antigen dose), and sustained ERK1 and ERK2 phosphorylation. Furthermore, we showed that activation of ERK1 and ERK2 is a requirement for production of IL-10 by Th1, Th2, and Th17 cell subsets. This common but highly regulated pathway for IL-10 induction and maintenance ensures its function as a feedback loop to control damage to the host and also allows a protective response to ensue as opposed to chronic infection.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
IL-12 and High Doses of Antigen Induce the Development of Th1 Cells Producing IL-10
###end title 14
###begin p 15
###xml 128 129 124 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 331 373 323 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13 bib23" ref-type="bibr">Constant et&#160;al., 1995; Hosken et&#160;al., 1995</xref>
###xml 391 400 383 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Figure&#160;S1</xref>
###xml 575 584 567 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Figure&#160;S1</xref>
###xml 608 609 600 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 851 860 839 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Figure&#160;S1</xref>
To study the differentiation of Th1 cells coproducing IFN-gamma and IL-10, we cultured purified TCR-transgenic DO11.10 naive CD4+ T cells with purified DCs as APCs and increasing doses of ovalbumin peptide 323-339 (OVA). Culture with high doses of antigen for 7 days gave rise to Th1 cells expressing IFN-gamma upon restimulation (Constant et al., 1995; Hosken et al., 1995), but not IL-10 (Figure S1A available online). Culture with low antigen doses under the same conditions led to the differentiation of Th2 cells, which expressed both IL-4 and IL-10 upon restimulation (Figure S1A). Culture of naive CD4+ T cells in an APC-free system by stimulation with anti-CD3 and anti-CD28 antibodies in the presence of IL-12 resulted in IFN-gamma-producing Th1 cells, a proportion of which coproduced IL-10, as did Th2 cells resulting from culture in IL-4 (Figure S1B).
###end p 15
###begin p 16
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 521 529 517 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure&#160;1</xref>
###xml 669 677 665 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure&#160;1</xref>
###xml 732 741 728 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figures 1</xref>
###xml 964 972 956 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure&#160;1</xref>
###xml 1038 1039 1030 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1084 1092 1076 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Table S1</xref>
###xml 1239 1240 1231 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1538 1547 1530 1539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Figure&#160;S2</xref>
###xml 1618 1619 1607 1608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1629 1670 1618 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib31 bib44" ref-type="bibr">Kitani et&#160;al., 2003; Schiott et&#160;al., 2000</xref>
###xml 1853 1862 1839 1848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Figure&#160;S3</xref>
To investigate whether the lack of IL-10 produced by Th1 cells resulted from inhibition of IL-10 production by DCs and high antigen dose or alternatively required IL-12, we cultured naive CD4+ T cells with increasing doses of antigen presented by DC in the presence of IL-12. At low doses of antigen, IL-12 abrogated the development of Th2 cells and induced IFN-gamma expression but only low levels of IL-10 expression, suggesting that IL-12 per se was not sufficient to induce significant IL-10 production in Th1 cells (Figure 1A). Strikingly, as the antigen dose was increased, Th1 populations driven with IL-12 now contained higher numbers of IL-10-producing cells (Figure 1A) and produced more IL-10 protein upon restimulation (Figures 1A and 1B). Thus, the development of Th1 cells producing IL-10 required both IL-12 and high doses of antigen. Th1 cells differentiated to produce large amounts of IL-10 and IFN-gamma and lost their capacity to produce IL-2 (Figure 1B). Because the presence of IL-12 reduced the proliferation of CD4+ T cells at both high and low antigen doses (Table S1), and only the former showed IL-10 production, the development of high IL-10-producing cells is most likely not related to limited IL-2. Naive CD4+ T cells from DO11.10/recombination-activating gene 1 (Rag1)-deficient animals, cultured with high doses of antigen in the presence of IL-12, also resulted in IL-10 expression by Th1 cells, showing that this expression was not dependent on the presence of effector or memory T cells or Treg cells (Figure S2). Although it has been suggested that TGF-beta can induce IL-10 in CD4+ T cells (Kitani et al., 2003; Schiott et al., 2000), we found that in developing Th1 and Th2 cells this was not the case (data not shown). In fact, neutralization of TGF-beta led to increased IL-10 production by both T cell subsets (Figure S3). Thus, the development of IL-10-producing Th1 cells only depended on the presence of IL-12 together with high antigen dose and not on other soluble factors such as IL-2 or TGF-beta or on the presence of other T cell types.
###end p 16
###begin title 17
IL-10 Production by Th1 Cells Is Dependent on STAT4 but Not on STAT6, IFN-gamma, or IL-4 Signaling
###end title 17
###begin p 18
###xml 180 199 180 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37" ref-type="bibr">Murphy et&#160;al., 2000</xref>
###xml 211 212 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 249 268 249 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib40" ref-type="bibr">Ouyang et&#160;al., 1998</xref>
###xml 441 449 441 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure&#160;2</xref>
###xml 663 671 659 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure&#160;2</xref>
To further elucidate the mechanisms required for the development of Th1 cells producing IL-10, we investigated the role of STAT4, one of the signaling pathways activated by IL-12 (Murphy et al., 2000). Naive CD4+ D011.10 T cells deficient in STAT4 (Ouyang et al., 1998) were cultured in the presence of IL-12 and OVA. Again, IL-10-producing Th1 cells were differentiated at the high antigen dose in the presence of IL-12 in DO11.10 T cells (Figure 2A). In contrast, in the absence of STAT4, the percentage of cells expressing IFN-gamma was dramatically diminished as expected and resulted in an increase in the percentage of cells expressing IL-4, but not IL-10 (Figure 2A), suggesting that STAT4 contributes to IL-10 expression by Th1 cells.
###end p 18
###begin p 19
###xml 227 273 227 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19 bib37" ref-type="bibr">Glimcher and Murphy, 2000; Murphy et&#160;al., 2000</xref>
###xml 395 403 395 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure&#160;2</xref>
###xml 519 527 515 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure&#160;2</xref>
###xml 738 747 734 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figures 2</xref>
###xml 868 877 864 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figures 2</xref>
###xml 1027 1036 1023 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figures 2</xref>
Because IL-10 expression is associated with an IL-4-induced Th2 cell phenotype, we investigated whether the differentiation of the IL-10-producing Th1 cells depended on signaling through the IL-4 receptor via STAT6 activation (Glimcher and Murphy, 2000; Murphy et al., 2000). The absence of STAT6 did not impair the differentiation of IL-10-producing Th1 cells in the presence of IL-12 and OVA (Figure 2A). In fact, a higher percentage of STAT6-deficient cells compared with WT cells produced both IL-10 and IFN-gamma (Figure 2A), which may be the result of the loss of Th2 cell control over a Th1 cell response. As expected, lack of STAT6 abrogated both IL-4 and IL-10 production by T cells developed with IL-4 or with low antigen dose (Figures 2B and 2C). However, in the absence of STAT4 signaling, IL-10 and IL-4 production by Th2 cells was if anything increased (Figures 2B and 2C). Thus, in contrast to what was observed under Th1 conditions, IL-10 expression by Th2 cells depended on STAT6, but not on STAT4, signaling (Figures 2B and 2C).
###end p 19
###begin p 20
###xml 144 161 140 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib45" ref-type="bibr">Shaw et&#160;al., 2006</xref>
###xml 230 231 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 405 413 393 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure&#160;2</xref>
To investigate whether the inability of STAT4-deficient T cells to produce IL-10 might be due to the absence of IFN-gamma, as suggested before (Shaw et al., 2006), we differentiated DO11.10 or DO11.10 IFN-gamma-deficient naive CD4+ T cells in the presence of IL-12 and increasing doses of OVA. The secretion of IL-10 as induced by high antigen dose, and IL-12 was not affected by an absence of IFN-gamma (Figure 2D), showing that the expression of IL-10 by Th1 cells is independent of IFN-gamma. In the absence of IFN-gamma, we observed an increase in the secreted IL-4 as expected (data not shown).
###end p 20
###begin p 21
###xml 150 151 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 241 249 241 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure&#160;2</xref>
###xml 332 340 332 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure&#160;2</xref>
###xml 406 414 406 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Figure&#160;2</xref>
We also tested for any potential role of IL-4 in the development of Th1 cells producing IL-10 by culturing DO11.10 or DO11.10 IL-4-deficient naive CD4+ T cells with IL-12 and increasing doses of antigen. As observed in the absence of STAT6 (Figure 2A), IL-4 deficiency had no effect on the development of Th1 cells producing IL-10 (Figure 2E), but compromised the development of Th2 cells producing IL-10 (Figure 2F). Thus, our data suggested that IL-10 production by Th1 or Th2 cells was dependent on the specific signaling pathways required for their differentiation, given that STAT4 is required for the induction of IL-10 production by Th1 cells and STAT6 for Th2 cells.
###end p 21
###begin title 22
High Antigen Doses and STAT4 Are Required for the In Vivo Generation of IL-10-Producing Th1 Cells
###end title 22
###begin p 23
###xml 526 534 522 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figure&#160;3</xref>
###xml 978 987 968 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figures 3</xref>
###xml 1259 1268 1249 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Figures 3</xref>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
To address the mechanisms regulating IL-10 production by Th1 cells in vivo, we transferred DO11.10 cells into BALB/c recipient mice and immunized the recipients with very high doses of OVA-protein with or without added lipopolysacharide (LPS). T cells were recovered from the inguinal lymph nodes 3 days after priming and restimulated in vitro with OVA peptide for 48 hr. This in vivo immunization induced IL-10 and IFN-gamma production, and the amount of IL-10 production was enhanced by addition of LPS in the immunization (Figure 3A) and with higher doses of OVA (3 muM versus 1 muM, data not shown). To test the role of STAT4 and STAT6 signaling in the in vivo development of IL-10-producing Th1 cells, we transferred STAT4- or STAT6-deficient or WT DO11.10 cells into recipient BALB/c mice and immunized with OVA-protein plus LPS as before. In vivo expression of both IL-10 and IFN-gamma was markedly reduced but not completely abrogated in the absence of STAT4 signaling (Figures 3B and 3C), suggesting the existence of compensatory mechanisms that were absent in the in vitro system. Signaling through STAT6 had no effect on IL-10 production by Th1 cells as shown by intracellular cytokine staining (ICS) and by immunoassay in STAT6-deficient T cells (Figures 3B and 3C).
###end p 23
###begin title 24
IL-10 Production Is Maintained by High TCR Signal Strength and IL-12
###end title 24
###begin p 25
###xml 172 173 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 298 307 298 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figures 4</xref>
###xml 389 398 389 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figures 4</xref>
###xml 730 739 730 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figures 4</xref>
###xml 859 867 859 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figure&#160;4</xref>
We next investigated whether repeated strong TCR activation is a compensatory signal for IL-12-induced STAT4 signaling in the induction of IL-10 in Th1 cells. For this, CD4+ T cells were differentiated for 2 consecutive weeks with high antigen doses in the presence or absence of IL-12 throughout (Figures 4A-4D). High antigen dose and IL-12 cooperated to induce maximal IL-10 production (Figures 4A and 4B), given that this combination resulted in the highest numbers of IL-10-producing Th1 cells. Repeated high antigen dose stimulation in the absence of exogenously added IL-12 resulted in the production of IL-10 by Th1 cells, suggesting that repeated strong TCR triggering may overcome the need for IL-12 for IL-10 induction (Figures 4C and 4D). However, IL-10 induction under these conditions was abrogated when IL-12p40-deficient DCs were used as APCs (Figure 4E). Thus, IL-12 is essential during both primary and secondary antigenic stimulation for production of IL-10 by Th1 cells.
###end p 25
###begin p 26
###xml 99 100 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 167 176 167 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figures 4</xref>
###xml 312 320 312 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figure&#160;4</xref>
###xml 593 601 593 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Figure&#160;4</xref>
###xml 716 717 716 717 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 989 998 985 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Figure&#160;S4</xref>
To determine the requirements for stability of the IL-10-producing Th1 cells, we differentiated CD4+ T cells for 1 week with high antigen doses with or without IL-12 (Figures 4A and 4C), washed them, and then restimulated them for an additional week with a low antigen dose, in the absence or presence of IL-12 (Figure 4F). Th1 cells induced in the first week to produce IL-10 by culture with high antigen doses and IL-12 lost their ability to express IL-10 when recultured with low doses of OVA, which could be compensated for, to some extent, by addition of IL-12 to the secondary cultures (Figure 4F), again suggesting that antigen dose and IL-12 signals cooperate for the induction of IL-10. Finally, DO11.10 CD4+ cells that were exposed to low doses of antigen and IL-12 during the primary differentiation phase produced high amounts of IFN-gamma but little IL-10, but they could be induced to produce IL-10 when both high antigen dose and IL-12 were present during the recall phase (Figure S4). Thus, high antigen dose and IL-12 are required for sustaining the induction of IL-10 production by Th1 cells.
###end p 26
###begin title 27
IL-10 Production by Th1 Cells Requires ERK1 and ERK2 Activation
###end title 27
###begin p 28
###xml 341 342 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 396 418 396 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr">Jorritsma et&#160;al., 2003</xref>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 500 508 500 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Figure&#160;5</xref>
###xml 852 860 852 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Figure&#160;5</xref>
Our data showed that the maintenance of IL-10 induction in Th1 cells required stimulation with high antigen dose, which to some extent could be compensated for by the addition of IL-12. Signaling through the TCR with high doses of antigen induced stronger ERK1 and ERK2 activation than that induced by low antigen dose, not only in naive CD4+ T cells (data not shown) as previously demonstrated (Jorritsma et al., 2003) but also in CD4+ T cells restimulated with the same high and low antigen doses (Figure 5A). Although the apparent peak and amount of ERK1 and ERK2 activation varied slightly between experiments, a consistent finding was that high antigen dose differentiated Th1 cells always showed enhanced and prolonged ERK1 and ERK2 activation in the presence of IL-12, regardless of whether they were restimulated with high or low antigen dose (Figure 5B).
###end p 28
###begin p 29
###xml 123 131 123 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Figure&#160;5</xref>
###xml 570 578 566 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Figure&#160;5</xref>
###xml 676 684 672 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Figure&#160;5</xref>
###xml 819 855 815 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5 bib34" ref-type="bibr">Bain et&#160;al., 2007; Mody et&#160;al., 2001</xref>
###xml 1013 1049 1009 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5 bib34" ref-type="bibr">Bain et&#160;al., 2007; Mody et&#160;al., 2001</xref>
###xml 1151 1159 1147 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Figure&#160;5</xref>
###xml 1165 1174 1161 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Figure&#160;S5</xref>
###xml 1313 1330 1306 1323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr">Bain et&#160;al., 2007</xref>
###xml 1377 1386 1370 1379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Figure&#160;S5</xref>
We then investigated whether ERK1 and ERK2 activation was required for the induction of IL-10 in Th1 cells by using U0126 (Figure 5C), a compound that blocks downstream ERK activation. To ensure that only T cell signaling was being affected by U0126, we used an APC-free system in which the T cells were differentiated in the presence of increasing doses of anti-CD3 and a constant amount of IL-12. As in the APC-driven cultures, stronger TCR stimulation together with IL-12 led to higher percentages of cells producing both IL-10 and IFN-gamma after 1 week of culture (Figure 5C). Addition of U0126 to the cultures abrogated the production of IL-10 at all doses of anti-CD3 (Figure 5C). Because U0126 inhibits the MEK5-catalyzed activation of ERK5, as well as the MEK1- and MEK2-catalyzed activation of ERK1 and ERK2 (Bain et al., 2007; Mody et al., 2001), we also used the more specific, structurally unrelated MEK1 and MEK2 inhibitor PD184352 at concentrations in which it inhibits MEK1 and MEK2 but not MEK5 (Bain et al., 2007; Mody et al., 2001). PD184352 caused a similar inhibition of IL-10 production by Th1 cells in a dose-dependent fashion (Figure 5D and Figure S5A). Upon addition of inhibitors to other signaling pathways, including a p38 MAPK inhibitor, SB203580, or the GSK3beta inhibitor, CT99021 (Bain et al., 2007), no effect on IL-10 production was observed (Figure S5B). Our data thus suggested that IL-10 production by Th1 cells in response to high antigen dose and IL-12 requires ERK1 and ERK2 signaling, but not the activation of the p38 or the GSK3beta pathways.
###end p 29
###begin title 30
IL-10 Production by Th2 and Th17 Cells Also Requires ERK1 and ERK2 Activation
###end title 30
###begin p 31
###xml 188 256 188 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib46 bib51 bib52" ref-type="bibr">Shoemaker et&#160;al., 2006; Veldhoen et&#160;al., 2009; Veldhoen et&#160;al., 2006</xref>
###xml 564 572 564 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Figure&#160;5</xref>
###xml 578 587 578 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Figure&#160;S5</xref>
###xml 711 720 708 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Figure&#160;S5</xref>
To address whether IL-10 production by Th2 and Th17 cells was also dependent on ERK1 and ERK2 activation, we differentiated these cells with anti-CD3 and anti-CD28 in the absence of APCs (Shoemaker et al., 2006; Veldhoen et al., 2009; Veldhoen et al., 2006), in the presence or absence of the MEK inhibitor (PD184352). We showed that ERK1 and ERK2 activation is a common pathway required for induction of IL-10 in different Th cell subsets because IL-10 production by both Th2 and Th17 cells was markedly inhibited in the presence of the MEK inhibitor (PD184352) (Figure 5D and Figure S5B). In contrast, inhibitors of p38 MAPK or of GSK-3beta activation did not affect the expression of IL-10 by these subsets (Figure S5B). Activation of the ERK1 and ERK2 signaling pathway is therefore a common requirement for the induction of IL-10 production by Th1, Th2, and Th17 cells.
###end p 31
###begin title 32
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-maf</italic>
c-maf Expression Correlates with IL-10 Production in Th1, Th2, and Th17 Cells
###end title 32
###begin p 33
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 329 332 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il4</italic>
###xml 394 402 394 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 439 442 439 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ifn</italic>
###xml 607 615 603 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 635 639 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il10</italic>
###xml 704 707 700 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il4</italic>
###xml 800 803 796 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il4</italic>
###xml 816 824 812 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 912 920 908 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 957 965 953 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure&#160;1</xref>
###xml 1009 1013 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il10</italic>
###xml 1039 1047 1035 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ifn&#947;</italic>
###xml 1089 1097 1081 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 1141 1149 1133 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure&#160;1</xref>
To investigate further the downstream factors involved in regulating IL-10 production, we differentiated DO11.10 CD4+ T cells with increasing doses of OVA, in the presence or absence of IL-12, and quantified the expression of cytokines and transcription factors by real-time RT-PCR. Low-dose antigen resulted in transcription of Il4 and this was abrogated by both high antigen doses and IL-12 (Figure 6A). A low amount of transcription of Ifngamma was induced by IL-12 when cells were differentiated with low antigen dose, but this effect of IL-12 was markedly upregulated with increasing doses of antigen (Figure 6A). A low amount of Il10 transcription was observed at low doses of antigen accompanying Il4 expression (Th2 cell response), and this was abrogated by increased doses of antigen as was Il4 expression (Figure 6A). At low doses of antigen, IL-12 had little effect to increase IL-10 mRNA expression (Figure 6A) in keeping with the protein data (Figure 1A). However, IL-12 induced a high amount of Il10 transcription as well as Ifngamma expression with increased antigen doses (Figure 6A), again in keeping with the protein data (Figure 1A).
###end p 33
###begin p 34
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 154 162 154 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 299 307 299 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 414 422 414 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-maf</italic>
###xml 542 557 542 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">Ho et&#160;al., 1996</xref>
###xml 630 638 630 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 741 749 741 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 784 789 784 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-maf</italic>
CD4+ T cells differentiated with increasing doses of antigen did not express high amounts of Tbx-21 (T-bet) mRNA, unless they were cocultured with IL-12 (Figure 6B). In contrast, high amounts of GATA-3 mRNA expression were only observed under Th2 cell differentiation conditions (low-dose antigen) (Figure 6B), and this expression was markedly downregulated by both increasing antigen dose and coculture in IL-12 (Figure 6B). Differentiation of T cells under low antigen dose led to expression of c-maf, in keeping with the Th2 cell profile (Ho et al., 1996), which was almost completely abrogated by increasing doses of antigen (Figure 6B). Interestingly, IL-12 sustained the high expression of c-Maf mRNA even at the highest antigen dose (Figure 6B). Moreover, IL-12 maintenance of c-maf expression required STAT4 activation (data not shown).
###end p 34
###begin p 35
###xml 59 67 59 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 166 174 162 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 178 197 174 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib26" ref-type="bibr">Ivanov et&#160;al., 2007</xref>
###xml 242 247 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-maf</italic>
###xml 249 257 245 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
###xml 289 309 285 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr">Bauquet et&#160;al., 2009</xref>
###xml 392 401 388 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figures 6</xref>
###xml 495 510 491 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">Ho et&#160;al., 1996</xref>
###xml 538 542 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il10</italic>
###xml 555 560 551 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-maf</italic>
###xml 675 680 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T-bet</italic>
###xml 685 694 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ROR&#947;t</italic>
###xml 727 735 719 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Figure&#160;6</xref>
In Th17 cells that expressed IL-17a as well as IL-10 mRNA (Figure 6C), T-bet and GATA-3 mRNA were undetectable (data not shown), whereas that of ROR-gammat was high (Figure 6C) (Ivanov et al., 2007). Th17 cells also expressed high amounts of c-maf (Figure 6C), confirming a recent report (Bauquet et al., 2009). c-Maf is therefore expressed in all IL-10-expressing T cell populations tested (Figures 6B and 6C) and may not be just a Th2 cell-specific transcription factor as originally thought (Ho et al., 1996). We showed also that like Il10 expression, c-maf expression was inhibited in Th1 and Th17 cells in the presence of the MEK1 and MEK2 inhibitor (PD184352), whereas T-bet and RORgammat expression was hardly affected (Figure 6D).
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 520 536 520 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib50" ref-type="bibr">Trinchieri, 2007</xref>
IL-10 expression by cells of the innate and adaptive immune systems reflects the importance of this cytokine in the tight regulation of the immune response, to minimize pathology during infection. IL-10 expression by Th1 cells has been reported to regulate the immune response in leishmaniasis and toxoplasmosis. However, in many situations, IL-10 is not produced by Th1 cells in response to antigenic stimulation. Our goal was to address the molecular signals that determine whether Th1 cells develop to produce IL-10 (Trinchieri, 2007). Here, we showed that Th1 cells required high-antigen-dose-induced ERK1 and ERK2 phosphorylation and IL-12-induced STAT-4 activation to produce IL-10. Our findings that ERK1 and ERK2 activation was a common pathway required for the production of IL-10 by Th1, Th2, and Th17 cell subsets, which differentiate along distinct pathways, such that IL-10 provides a highly regulated feedback loop to avoid the extremes of excessive inflammation or chronic infections and also allow a protective response to diverse pathogens.
###end p 37
###begin p 38
###xml 42 106 42 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib9 bib15" ref-type="bibr">Anderson et&#160;al., 2007; Brooks et&#160;al., 2006; Ejrnaes et&#160;al., 2006</xref>
###xml 576 577 576 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 633 652 633 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">Gerosa et&#160;al., 1999</xref>
###xml 711 719 711 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. major</italic>
###xml 826 827 826 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 874 895 870 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr">Anderson et&#160;al., 2007</xref>
###xml 929 938 925 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 988 989 984 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1001 1022 997 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib27" ref-type="bibr">Jankovic et&#160;al., 2007</xref>
###xml 1170 1171 1166 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1331 1339 1327 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. major</italic>
###xml 1359 1400 1355 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8 bib49" ref-type="bibr">Belkaid et&#160;al., 2002; Suffia et&#160;al., 2006</xref>
###xml 1432 1433 1428 1429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1688 1709 1680 1701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib43" ref-type="bibr">Sallusto et&#160;al., 2004</xref>
###xml 623 631 <span type="species:ncbi:9606">patients</span>
###xml 711 719 <span type="species:ncbi:5664">L. major</span>
###xml 929 938 <span type="species:ncbi:5811">T. gondii</span>
###xml 1331 1339 <span type="species:ncbi:5664">L. major</span>
In certain viral or parasitic infections (Anderson et al., 2007; Brooks et al., 2006; Ejrnaes et al., 2006), high amounts of stimulation may lead to the chronic nonhealing infection shown to be regulated by IL-10. During the course of infection, after initial triggering with antigen, T cells migrate to the tissue encountering high doses of antigen and factors produced by the innate immune response. Under these conditions, we speculate that Th1 cells will be induced to express high amounts of IL-10, in keeping with reports that IL-10-producing Th1 cells were found in CD4+ clones isolated from BAL but not blood of TB patients (Gerosa et al., 1999). Similarly, the immune response to a clinical isolate of L. major, which produces heavily infected nonhealing lesions, was found to be regulated by IL-10 derived from Foxp3- Th1 cells that coproduce IL-10 and IFN-gamma (Anderson et al., 2007), and the immune response during T. gondii infection was found also to be regulated by Foxp3- Th1 cells (Jankovic et al., 2007). It is likely that IL-10 production by Th1 cells is evoked under conditions of high inflammation and antigenic stimulation, whereas regulatory CD4+ T cells producing IL-10 may operate to regulate the immune response under conditions in which the pathogen is clinically controlled, such as in infection with L. major (Friedlin strain) (Belkaid et al., 2002; Suffia et al., 2006). We now also reported that CD4+ T cells cultured with high antigen dose and IL-12 differentiate into canonical Th1 effector cells, which, in addition to expressing large amounts of IFN-gamma and IL-10, lose their IL-2 expression as described before in certain chronic infection models (Sallusto et al., 2004). Our demonstration that loss of IL-2 is accompanied by production of IL-10 offers potential additional mechanisms whereby effector T cell responses may be dampened during chronic disease.
###end p 38
###begin p 39
###xml 65 84 65 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">Castro et&#160;al., 2000</xref>
###xml 352 361 352 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 373 394 373 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr">Jankovic et&#160;al., 2002</xref>
###xml 432 441 432 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 352 361 <span type="species:ncbi:5811">T. gondii</span>
###xml 432 441 <span type="species:ncbi:5811">T. gondii</span>
Using an in vivo transfer model of DO11.10 TCR transgenic cells (Castro et al., 2000), we showed that IL-10-producing Th1 cells were differentiated in the presence of high doses of OVA protein and LPS. We showed here that this induction of IL-10 in Th1 cells in vivo was markedly, but not totally, reduced in STAT4-deficient T cells as observed during T. gondii infection (Jankovic et al., 2002). A high antigenic activation during T. gondii infection or high antigen doses delivered in the presence of LPS, as seen in our system, may compensate for an absolute requirement for IL-12 in the induction of IL-10 by Th1 cells.
###end p 39
###begin p 40
###xml 299 320 295 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr">Jankovic et&#160;al., 2002</xref>
###xml 430 439 422 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 460 477 452 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib45" ref-type="bibr">Shaw et&#160;al., 2006</xref>
###xml 502 503 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1213 1222 1201 1210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. gondii</italic>
###xml 1242 1259 1230 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib45" ref-type="bibr">Shaw et&#160;al., 2006</xref>
###xml 430 439 <span type="species:ncbi:5811">T. gondii</span>
###xml 1213 1222 <span type="species:ncbi:5811">T. gondii</span>
In our in vitro system, repeated stimulation of Th1 cells with high antigen doses allowed the development of Th1 cells producing IL-10 in an IL-12-dependent manner. IL-10 production by Th1 cells induced by high antigen dose and IL-12 was independent of IFN-gamma, in keeping with previous findings (Jankovic et al., 2002). However, a role for IFN-gamma in mediating IL-10 reactivation by Th1 cells during secondary infection with T. gondii has been suggested (Shaw et al., 2006). We have found that CD4+ T cells exposed to a high dose of antigen do not express IL-10 upon restimulation, but can be induced to produce IL-10 upon re-exposure to a high dose of antigen in the recall phase in the absence of added IL-12. However, this is dependent on the induction of IL-12 by antigen-presenting DCs. The combination of both high antigen dose and IL-12 resulted in the highest levels of IL-10 production and correlated with the high levels of ERK1 and ERK2 activation. The increased expression of IFN-gamma observed during the secondary phase will induce increased IL-12 production by DCs and suggests that repeated high-level TCR activation feeds back to upregulate IL-12 production by DC. It is thus likely that in T. gondii infection in vivo (Shaw et al., 2006), the requirement for IFN-gamma to induce IL-10, was for feedback upregulation of IL-12 by DCs, which in turn induced IL-10 in the Th1 cells.
###end p 40
###begin p 41
###xml 90 127 90 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib53" ref-type="bibr">Chang et&#160;al., 2007; Wang et&#160;al., 2005</xref>
###xml 323 339 323 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr">Ito et&#160;al., 2005</xref>
###xml 427 464 427 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25 bib55" ref-type="bibr">Ito et&#160;al., 2007; Witsch et&#160;al., 2002</xref>
###xml 582 604 582 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">Greenwald et&#160;al., 2005</xref>
###xml 1139 1180 1139 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1 bib21" ref-type="bibr">Agrawal et&#160;al., 2006; Hacker et&#160;al., 1999</xref>
Although IL-10 may be differentially regulated in Th1 and Th2 cells as has been reported (Chang et al., 2007; Wang et al., 2005), some studies suggest the existence of common pathways, but the molecular basis for these is as yet unclear. Costimulatory OX-40 signals have been shown to negatively regulate IL-10 production (Ito et al., 2005) both in Th1 and Th2 cells, whereas ICOS signaling has been suggested to induce IL-10 (Ito et al., 2007; Witsch et al., 2002) in both Th1 and Th2 cells. However, in some cases, ICOS signaling also regulates IL-4 production and Th2 responses (Greenwald et al., 2005). We now provide a common mechanism of ERK1 and ERK2 activation for the regulation of IL-10 production in Th1, Th2, and Th17 cells, although each subset differentiates along a distinct and subset-specific transcriptional pathway. This reinforces the fact that IL-10 is not a Th cell-subset-specific cytokine, but instead is produced in a tightly regulated fashion during each differentiation pathway. Of note, a role for ERK1 and ERK2 activation in the induction of IL-10 production has already been described for macrophages and DC (Agrawal et al., 2006; Hacker et al., 1999).
###end p 41
###begin p 42
###xml 90 127 90 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib53" ref-type="bibr">Chang et&#160;al., 2007; Wang et&#160;al., 2005</xref>
###xml 245 263 245 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">Chang et&#160;al., 2007</xref>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T-bet</italic>
###xml 709 727 701 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">Chang et&#160;al., 2007</xref>
###xml 833 875 825 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12 bib46" ref-type="bibr">Chang et&#160;al., 2007; Shoemaker et&#160;al., 2006</xref>
###xml 949 955 941 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gata-3</italic>
###xml 1091 1096 1083 1088 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-maf</italic>
###xml 1230 1235 1222 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-maf</italic>
###xml 1511 1527 1503 1519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr">Cao et&#160;al., 2005</xref>
Differential transcriptional regulation of IL-10 in Th1 and Th2 cells has been suggested (Chang et al., 2007; Wang et al., 2005), and extensive histone acetylation of the IL-10 gene is detectable in fully polarized Th2 cells, but not Th1 cells (Chang et al., 2007). We provide evidence that IL-10 is produced in canonical Th1 cells and that its expression correlates with the expression of T-bet and the highest IFN-gamma production, in keeping with our observations that high-dose antigen stimulation and IL-12 signaling are required for IL-10 and IFN-gamma expression. It has also been shown that maintenance of IL-10 expression is conditional on IL-12 or IL-4 unless the IL-10 gene is imprinted by GATA-3 (Chang et al., 2007), which can remodel the IL-10 locus, thus explaining the highest amounts of IL-10 produced by Th2 cells (Chang et al., 2007; Shoemaker et al., 2006). We show here that high antigen dose and IL-12 drastically downregulate Gata-3 expression, suggesting that additional factors are in place to induce IL-10 expression in Th1 cells, albeit transiently. Expression of c-maf was greatly diminished by high antigen doses in T cells and yet was unexpectedly maintained by IL-12 and present in Th17 cells. That c-maf expression is common to IL-10-producing Th1, Th2, and Th17 cells and, like IL-10, is dependent on ERK activation in Th1 and Th17 cells for its expression is of interest because c-Maf has been shown to be an essential transcription factor for IL-10 expression in macrophages (Cao et al., 2005).
###end p 42
###begin p 43
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In summary, we show that although Th1, Th2, and Th17 CD4+ T cell subsets differentiate along distinct signaling and transcriptional pathways, they can all be induced to make IL-10. ERK1 and ERK2 activation is required for IL-10 production by all these Th cell subsets. With regard to the expression of IL-10 by Th1 cells, our data provide a mechanism for how IL-10 expression is induced and then amplified and regulated by the levels of antigen and IL-12 encountered in the environment. This provides a mechanism whereby a Th1 cell responds to extrinsic signals, reflecting increased inflammation in the tissue, to tightly regulate the production of IL-10 so as to allow a protective response to eradicate a pathogen with minimal damage to the host and also prevent chronic infection. Moreover, our findings have important implications for the regulation of IL-10 production during an inflammatory Th1 response in infection and may be of relevance for the design of vaccines and for strategies in immunotherapy in infectious diseases.
###end p 43
###begin title 44
Experimental Procedures
###end title 44
###begin title 45
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice, Cytokines, Antibodies, and Other Reagents
###end title 45
###begin p 46
###xml 186 250 182 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib36 bib40 bib46" ref-type="bibr">Murphy et&#160;al., 1990; Ouyang et&#160;al., 1998; Shoemaker et&#160;al., 2006</xref>
###xml 730 819 726 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23 bib46 bib51 bib52" ref-type="bibr">Hosken et&#160;al., 1995; Shoemaker et&#160;al., 2006; Veldhoen et&#160;al., 2009; Veldhoen et&#160;al., 2006</xref>
###xml 827 839 823 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S. minnesota</italic>
###xml 948 955 944 951 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">323-339</sub>
###xml 15 19 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 827 839 <span type="species:ncbi:70803">S. minnesota</span>
###xml 858 865 <span type="species:ncbi:9031">chicken</span>
BALB/c DO11.10 mice transgenic for OVA-specific TCR WT or crossed back with Rag1-, IL-4-, IFN-gamma-, STAT4-, and STAT6-deficient mice were used as a source of antigen-specific T cells (Murphy et al., 1990; Ouyang et al., 1998; Shoemaker et al., 2006) and were bred and maintained under SPF conditions at the NIMR, London, Home Office, UK, Animals (Scientific Procedures) Act 1986 or at the Washington University School of Medicine. Female mice were used at 8-12 weeks old, and animal protocols were approved according to the Animals (Scientific Procedures) Act 1986, Home Office, UK. Reagents, including antibodies for T cell and DC preparation, purification and culture, media, cytokines, and cytokine mAbs have been described (Hosken et al., 1995; Shoemaker et al., 2006; Veldhoen et al., 2009; Veldhoen et al., 2006). LPS (S. minnesota) was from Alexis, chicken ovalbumin protein (OVA protein) was from from Sigma-Aldrich, and ovalbumin peptide323-339 (OVA) (endotoxin-free) was from Biosynthesis. U0126 was from BioMol International. PD184352 (MEK inhibitors), SB203580 (p38 inhibitor), and CT99021 (GSK3beta inhibitor) were kind gifts from P. Cohen and N. Shpiro, University of Dundee, UK.
###end p 46
###begin title 47
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Isolation of CD4+ T Cells and of Splenic DC and Cell Culture for T Cell Phenotype Differentiation
###end title 47
###begin p 48
###xml 27 28 27 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 52 53 52 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 61 62 61 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 66 68 66 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo</sup>
###xml 72 73 72 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 127 172 127 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib46 bib51" ref-type="bibr">Shoemaker et&#160;al., 2006; Veldhoen et&#160;al., 2009</xref>
###xml 248 249 248 249 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 339 358 339 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Hosken et&#160;al., 1995</xref>
###xml 384 385 384 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 446 447 446 447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 463 464 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 500 519 500 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">Hosken et&#160;al., 1995</xref>
###xml 605 606 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 703 704 703 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 883 926 883 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23 bib46" ref-type="bibr">Hosken et&#160;al., 1995; Shoemaker et&#160;al., 2006</xref>
###xml 989 1010 989 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib52" ref-type="bibr">Veldhoen et&#160;al., 2006</xref>
###xml 1086 1152 1086 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23 bib46 bib52" ref-type="bibr">Hosken et&#160;al., 1995; Shoemaker et&#160;al., 2006; Veldhoen et&#160;al., 2006</xref>
###xml 1214 1235 1214 1235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib51" ref-type="bibr">Veldhoen et&#160;al., 2009</xref>
###xml 1463 1480 1460 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="app2" ref-type="sec">Figures S6 and S7</xref>
T cells were sorted for CD4+CD62Lhi, CD4+CD62LhiCD25-, or CD4+CD44loCD25- to >98% on a Moflo cytometer (Cytomation) as before (Shoemaker et al., 2006; Veldhoen et al., 2009). In most cases, experiments were reproduced with each type of purified CD4+ T cell population with similar results obtained. Splenic DCs were prepared as described (Hosken et al., 1995), and sort purified CD11c+ cells were added to the T cell culture. Purified DO11.10 CD4+ T cells (1 x 105 cells/ml) were cultured as before (Hosken et al., 1995), in a total volume of 1 ml cRPMI medium in a 48-well plate, with splenic DCs (2 x 104 cells/ml), and varying amounts of OVA and of IL-12. APC-independent differentiation of naive CD4+ T cells into Th1 and Th2 cells used stimulation with anti-CD3 and anti-CD28 and appropriate cytokine conditions, and control Th1 and Th2 cells were cultured as described before (Hosken et al., 1995; Shoemaker et al., 2006). Culture conditions for Th17 cells were as described before (Veldhoen et al., 2006). Importantly, Th1 and Th2 cells could be differentiated in cRPMI or IMDM (Hosken et al., 1995; Shoemaker et al., 2006; Veldhoen et al., 2006), but Th17 cells were only differentiated optimally in IMDM (Veldhoen et al., 2009). When indicated, U0126 or PD184352 (MEK inhibitors), SB203580 (p38 inhibitor), CT99021 (GSK3beta inhibitor), or a similar amount of DMSO were present in the culture. More details of specific culture conditions are provided in Figures S6 and S7.
###end p 48
###begin title 49
Cytokine Detection by ICS and ELISA
###end title 49
###begin p 50
###xml 475 497 467 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib46" ref-type="bibr">Shoemaker et&#160;al., 2006</xref>
At day 5 or 7, cells were restimulated with immobilized anti-CD3 (2 mug/ml) and anti-CD28 (2 mug/ml) (4 hr with BrefeldinA [10 mug/ml] in the last 2 hr) or with PdBU and Ionomycin (5 hr with BrefeldinA [1 mug/ml]). After ICS FACS, data were collected on a FACSCalibur (Becton Dickinson) and analyzed with FlowJo (Tree Star). For ELISA, cells were similarly restimulated for 48 hr and supernatant was collected and analyzed for IL-4, IL-10, and IFN-gamma as described before (Shoemaker et al., 2006).
###end p 50
###begin title 51
In Vivo Studies
###end title 51
###begin p 52
###xml 117 118 117 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 127 146 127 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">Castro et&#160;al., 2000</xref>
###xml 372 373 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 7 11 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
BALB/c mice were injected intravenously (i.v.) with a red blood cell-depleted single-cell spleen suspension (2.5 x 107 cells) (Castro et al., 2000) from DO11.10 WT or STAT-deficient mice. After 48 hr, they were injected subcutaneously with PBS or with OVA protein (5 mg) plus LPS (5 mug). The inguinal lymph nodes were removed 48 hr later. A single-cell suspension (1 x 106 cells) was restimulated for 24 or 48 hr with 1 muM or 3 muM of OVA and with BrefeldinA for the last 6 hr. Half of the supernatant was removed before the addition of BrefeldinA for use in an ELISA assay. The cells were fixed and stained as before. Those positive for KJ1-26-Bio and for CD4-PerCP were gated, and IFN-gamma and IL-10 staining was examined for this population and analyzed as before.
###end p 52
###begin title 53
Real-Time Quantitative RT-PCR
###end title 53
###begin p 54
###xml 302 324 300 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib46" ref-type="bibr">Shoemaker et&#160;al., 2006</xref>
###xml 472 481 470 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ubiquitin</italic>
###xml 485 489 483 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
Cells were harvested and restimulated in the presence of immobilized anti-CD3 (2 mug/ml) plus anti-CD28 (2 mug/ml) for 3 hr or immediately lysed. RNA was extracted and reverse-transcribed and cDNA was analyzed for the expression of cytokines and transcription factors by real-time PCR assay as before (Shoemaker et al., 2006). Target gene mRNA expression was quantified either with SYBR Green (Applied Biosystems) or with Master Mix (Applied Biosystems) and normalized to ubiquitin or HPRT mRNA levels, respectively.
###end p 54
###begin title 55
Immunoblotting
###end title 55
###begin p 56
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 291 310 291 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr">Beinke et&#160;al., 2004</xref>
Differentiated CD4+ T cells were rested for 5 hr in 1% FCS-containing medium and restimulated as described for specific experiments. Cell lysates were prepared, equal amounts of protein were separated by SDS-PAGE, and phosphorylated or total ERK and actin were detected as described before (Beinke et al., 2004).
###end p 56
###begin title 57
Supplemental Data
###end title 57
###begin p 58
Supplemental Data include one table, five figures, and two experimental flowcharts and can be found with this article online at .
###end p 58
###begin title 59
Supplemental Data
###end title 59
###begin p 60
###xml 0 69 0 69 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="61">Document S1. One Table, Five Figures, and Two Experimental Flowcharts</title>
###xml 0 69 0 69 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="61">Document S1. One Table, Five Figures, and Two Experimental Flowcharts</title></caption>
###xml 69 69 69 69 <media xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/>
###xml 0 69 0 69 <supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="local-data" id="mmc1"><caption><title textid="61">Document S1. One Table, Five Figures, and Two Experimental Flowcharts</title></caption><media xlink:href="mmc1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material>
Document S1. One Table, Five Figures, and Two Experimental Flowcharts
###end p 60
###begin title 61
Document S1. One Table, Five Figures, and Two Experimental Flowcharts
###end title 61
###begin title 62
Acknowledgments
###end title 62
###begin p 63
We thank C. Atkins, A. Rae, G. Preece, and N. Biboum for assistance in flow cytometry and M. Holman for the help with the in vivo experiments. We also thank the National Institute for Medical Research (NIMR) Biological Services for their animal husbandry and breeding. We specially thank G. Trinchieri (National Cancer Institute, National Institutes of Health, USA), F. Barrat (Dynavax, CA, USA), B. Stockinger, S. Ley, and G. Kassiotis (NIMR, Mill Hill, UK) for critically reading the manuscript and offering helpful advice. We thank P. Cohen and N. Shpiro, University of Dundee, for their generosity in providing MAP kinase PD184352 and CT99021 inhibitor reagents, as well as advice on their use, and thank P. Cohen also for providing critical advice. This work was supported by the Medical Research Council, UK, (M.S., J.R.C., M.V., and A.O.G.) and Howard Hughes Medical Institute (K.M.M. and T.L.M.).
###end p 63
###begin title 64
References
###end title 64
###begin article-title 65
###xml 8 12 <span type="species:ncbi:10090">mice</span>
ERK1-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis
###end article-title 65
###begin article-title 66
CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis
###end article-title 66
###begin article-title 67
###xml 56 62 <span type="species:ncbi:10090">murine</span>
Flow cytometric determination of cytokines in activated murine T helper lymphocytes: Expression of interleukin-10 in interferon-gamma and in interleukin-4-expressing cells
###end article-title 67
###begin article-title 68
A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells
###end article-title 68
###begin article-title 69
The selectivity of protein kinase inhibitors: A further update
###end article-title 69
###begin article-title 70
The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells
###end article-title 70
###begin article-title 71
Lipopolysaccharide activation of the TPL-2/MEK/extracellular signal-regulated kinase mitogen-activated protein kinase cascade is regulated by IkappaB kinase-induced proteolysis of NF-kappaB1 p105
###end article-title 71
###begin article-title 72
###xml 37 53 <span type="species:ncbi:5664">Leishmania major</span>
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
###end article-title 72
###begin article-title 73
Interleukin-10 determines viral clearance or persistence in vivo
###end article-title 73
###begin article-title 74
The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages
###end article-title 74
###begin article-title 75
Anti-interleukin 10 receptor monoclonal antibody is an adjuvant for T helper cell type 1 responses to soluble antigen only in the presence of lipopolysaccharide
###end article-title 75
###begin article-title 76
Expression of IL-10 in Th memory lymphocytes is conditional on IL-12 or IL-4, unless the IL-10 gene is imprinted by GATA-3
###end article-title 76
###begin article-title 77
Extent of T cell receptor ligation can determine the functional differentiation of naive CD4+ T cells
###end article-title 77
###begin article-title 78
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production
###end article-title 78
###begin article-title 79
Resolution of a chronic viral infection after interleukin-10 receptor blockade
###end article-title 79
###begin article-title 80
Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells
###end article-title 80
###begin article-title 81
###xml 144 152 <span type="species:ncbi:9606">patients</span>
CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients
###end article-title 81
###begin article-title 82
###xml 22 27 <span type="species:ncbi:9606">human</span>
Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10
###end article-title 82
###begin article-title 83
Lineage commitment in the immune system: The T helper lymphocyte grows up
###end article-title 83
###begin article-title 84
The B7 family revisited
###end article-title 84
###begin article-title 85
Cell type-specific activation of mitogen-activated protein kinases by CpG-DNA controls interleukin-12 release from antigen-presenting cells
###end article-title 85
###begin article-title 86
The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4
###end article-title 86
###begin article-title 87
The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model
###end article-title 87
###begin article-title 88
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand
###end article-title 88
###begin article-title 89
Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand
###end article-title 89
###begin article-title 90
Transcriptional regulation of Th17 cell differentiation
###end article-title 90
###begin article-title 91
Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection
###end article-title 91
###begin article-title 92
In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(-/-) setting
###end article-title 92
###begin article-title 93
###xml 77 82 <span type="species:ncbi:9606">human</span>
IL-12 synergizes with IL-2 and other stimuli in inducing IL-10 production by human T cells
###end article-title 93
###begin article-title 94
Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4+ T cells
###end article-title 94
###begin article-title 95
Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis
###end article-title 95
###begin article-title 96
TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology
###end article-title 96
###begin article-title 97
###xml 34 39 <span type="species:ncbi:9606">human</span>
IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses
###end article-title 97
###begin article-title 98
Effects of MAP kinase cascade inhibitors on the MKK5/ERK5 pathway
###end article-title 98
###begin article-title 99
Interleukin-10 and the interleukin-10 receptor
###end article-title 99
###begin article-title 100
Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo
###end article-title 100
###begin article-title 101
Signaling and transcription in T helper development
###end article-title 101
###begin article-title 102
Regulatory T cells and mechanisms of immune system control
###end article-title 102
###begin article-title 103
T(H)1 cells control themselves by producing interleukin-10
###end article-title 103
###begin article-title 104
Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism
###end article-title 104
###begin article-title 105
###xml 83 91 <span type="species:ncbi:9606">patients</span>
###xml 105 125 <span type="species:ncbi:139">Borrelia burgdorferi</span>
Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection
###end article-title 105
###begin article-title 106
###xml 66 72 <span type="species:ncbi:9606">humans</span>
Interleukin-10-secreting type 1 regulatory T cells in rodents and humans
###end article-title 106
###begin article-title 107
Central memory and effector memory T cell subsets: Function, generation, and maintenance
###end article-title 107
###begin article-title 108
###xml 72 75 <span type="species:ncbi:10116">rat</span>
Association of decreased phosphorylation of ERK-2 with costimulation of rat T cell activation by MEK-1 inhibitors and TGF-beta1
###end article-title 108
###begin article-title 109
Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation
###end article-title 109
###begin article-title 110
GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+ T cells
###end article-title 110
###begin article-title 111
Differentiation and function of Th17 T cells
###end article-title 111
###begin article-title 112
Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10
###end article-title 112
###begin article-title 113
Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens
###end article-title 113
###begin article-title 114
Interleukin-10 production by effector T cells: Th1 cells show self control
###end article-title 114
###begin article-title 115
Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells
###end article-title 115
###begin article-title 116
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
###end article-title 116
###begin article-title 117
Regulation of IL-10 gene expression in Th2 cells by Jun proteins
###end article-title 117
###begin article-title 118
###xml 14 19 <span type="species:ncbi:9606">human</span>
IL-12 induces human T cells secreting IL-10 with IFN-gamma
###end article-title 118
###begin article-title 119
###xml 59 64 <span type="species:ncbi:9606">human</span>
ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells
###end article-title 119
###begin article-title 120
Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment
###end article-title 120
###begin p 121
IL-12 Enhances IL-10 Production at High Antigen Dose Only
###end p 121
###begin p 122
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Naive CD4+ T cells from DO11.10 TCR transgenic animals were isolated and differentiated for 1 week with splenic DCs in medium containing increasing doses of OVA in the absence (medium) or presence of IL-12, as indicated. On day 7, cells were restimulated for 4 hr with plate-bound anti-CD3 and soluble anti-CD28 and BrefeldinA and (A) stained at the single-cell level for IL-10, IFN-gamma, and IL-4, or (B) stimulated similarly for 48 hr in the absence of BrefeldinA, and the culture supernatants analyzed by ELISA. Data are representative of six experiments performed; error bars in (B) refer to the standard deviation of three independent cultures.
###end p 122
###begin p 123
IL-10 Production by Th1 Cells Requires IL-12-Induced STAT4 Activation
###end p 123
###begin p 124
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat4</italic>
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6</italic>
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 95 103 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ifn&#947;</italic>
###xml 103 106 99 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 132 135 128 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il4</italic>
###xml 135 138 131 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 189 197 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure&#160;1</xref>
###xml 534 542 523 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure&#160;1</xref>
CD4+ T cells from DO11.10 animals on a (A, B, and C) WT, Stat4-/-, or Stat6-/- background, (D) Ifngamma-/- background, or (E and F) Il4-/- background were isolated and differentiated as in Figure 1. As shown in (B), Th2-driven cells were differentiated for 1 week in medium containing IL-4 (10 ng/ml) and anti-IL-12 (10 mug/ml) plus 1 muM OVA; or (C and F) 0.05 muM OVA alone (low-antigen-dose-driven Th2 cells). On day 7, cells were restimulated and IL-10, IFN-gamma, and IL-4 production were detected by ICS or by immunoassay as in Figure 1. Represented is one of three experiments performed. Detection of cytokines by ELISA in the supernatants of cultures restimulated for 48 hr (data not shown) confirmed the results observed for ICS in (A) and (B). Error bars refer to the standard deviation of replicate values of three independent cultures.
###end p 124
###begin p 125
In Vivo Generation of IL-10-Producing Th1 Cells Requires High Antigen Dose, Innate Immune Signals and STAT4
###end p 125
###begin p 126
###xml 428 433 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat4</italic>
###xml 433 436 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 456 461 449 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6</italic>
###xml 461 464 454 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 838 839 826 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 846 847 834 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
(A) Spleen cell suspensions from DO11.10 animals were injected into BALB/c recipients. Cells were isolated from the inguinal lymph nodes of mice injected with PBS, OVA protein (5 mg) plus or minus LPS (5 mug) and restimulated in vitro with OVA for 48 hr. IL-10 and IFN-gamma production was analyzed by ELISA. Represented is the mean +/- SD of groups of three animals each. Spleen cell suspensions from DO11.10 WT (ten animals), Stat4-/- (nine animals), or Stat6-/- (ten animals) were transferred into BALB/c recipients, which were then injected with OVA protein and LPS (5 mg and 5 mug, respectively). Cells recovered as above were restimulated in vitro, for 24-48 hr with the last 6 hr in the presence (for ICS, B) or absence (for ELISA, C) of BrefeldinA. IL-10 and IFN-gamma expression was detected by ICS and represented within the CD4+ KJ1-26+ T cells population.
###end p 126
###begin p 127
###xml 332 337 314 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat4</italic>
###xml 337 340 319 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 346 351 328 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Stat6</italic>
###xml 351 354 333 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
(B) We obtained the plots represented by merging the plots from each mouse within one group. Two independent experiments confirmed the result showed and the mean percentage of IL-10/IFN-gamma producers +/- SD was 3.95 +/- 1.15 and 2.25 +/- 0.68; 4.29 +/- 1.36 and 7.11 +/- 1.86; and 3.82 +/- 0.96 and 10.19 +/- 2.25 for DO11.10 WT, Stat4-/-, and Stat6-/-, respectively.
###end p 127
###begin p 128
(C) Error bars refer to the standard deviation of replicate values on two independent experiments.
###end p 128
###begin p 129
High Antigen Dose and IL-12 Are Required for Maximal Production of IL-10 by Th1 Cells
###end p 129
###begin p 130
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 342 343 339 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 446 451 442 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Il12b</italic>
###xml 451 454 447 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
CD4+ T cells from DO11.10 TCR transgenic animals were cultured for 1 week with a high (0.7 muM) dose of OVA and DC in the (A and B) presence or (C) absence of IL-12 and subsequently washed, counted, and recultured with a high (0.7 muM; B, D, and E) or low (0.01 muM; F) dose of OVA and DC in the absence or presence of IL-12 as indicated. CD4+ T cells from DO11.10 TCR transgenic animals were cultured with a high (0.7 muM) dose of OVA and WT or Il12b-/- DCs in the absence of added IL-12 for 2 weeks (E). At the end of the first (A, C, and E) and the second week (B, D, E, and F), cells were restimulated with anti-CD3 and anti-CD28, and IFN-gamma and IL-10 cytokine expression were detected by ICS. Represented is one of three experiments performed.
###end p 130
###begin p 131
IL-10 Production by Th1, Th2, and Th17 Cells Requires ERK1 and ERK2 Activation
###end p 131
###begin p 132
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 589 590 585 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1126 1127 1117 1118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CD4+ T cells from DO11.10 TCR transgenic animals were cultured with a high (0.7 muM) or low (0.01 muM) dose of OVA and DC in the absence or presence of IL-12. On day 3, cells were harvested, rested for 5 hr in low (1%) serum medium, and restimulated with high (0.7 muM) or low (0.01 muM) antigen dose, in the (A and B) absence or in the (B) presence of IL-12, for the indicated time points. Cellular lysates were prepared, proteins were separated by SDS-PAGE, and phospho(p)- or total(t)-ERK1 and ERK2 were detected by immunoblotting. Actin was included as a loading control (A and B). CD4+ T cells from BALB/c animals were isolated and cultured for 7 days in the presence of increasing doses of plate-bound anti-CD3, soluble anti-CD28, and IL-12 (3 ng/ml), in the absence (control, with DMSO) or presence of U0126 (2.5 muM) (MEK Inhibitor). As shown in (C), on day 7, cells were restimulated as above and the expression of IL-10 and IFN-gamma was detected by ICS. Cytokine production in the supernatants of 48 hr restimulated cultures was analyzed by ELISA and confirmed the ICS results (data not shown). As shown in (D), CD4+ T cells from BALB/c animals were isolated and cultured for 5 days in the presence of plate-bound anti-CD3, soluble anti-CD28 and one of the following combinations: IL-12 (3 ng/ml) plus anti-IL-4 (20 mug/ml), for Th1; IL-4 (10 ng/ml) plus anti-IL-12 (10 mug/ml), for Th2; or IL-6 (50 ng/ml), TGF-beta (1 ng/ml) and IL-1 (10 ng/ml), for Th17, all in the absence (control, with DMSO) or presence of PD184352 MEK Inhibitor, as in (C). On day 5, cells were restimulated with PdBU and ionomycin, and the expression of IL-10, IFN-gamma, IL-4, and IL-17 was detected by ICS. Represented is one of three (A, B, C, and F) or one of four (D and E) experiments performed.
###end p 132
###begin p 133
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-maf</italic>
c-maf Is Expressed in IL-10-Producing Th1, Th2, and Th17 Cells
###end p 133
###begin p 134
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 318 326 318 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Figure&#160;1</xref>
###xml 331 332 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 655 663 652 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Figure&#160;5</xref>
CD4+ T cells from DO11.10 TCR transgenic animals were differentiated for 1 week in medium containing increasing doses of OVA plus DC in the absence (Med) or presence of IL-12, as indicated. On day 7, cells were (A) restimulated for cytokine expression or (B) not restimulated for transcription factor expression as in Figure 1. CD4+ T cells from C57Bl/6 animals were isolated and cultured for 5 days in the presence of plate-bound anti-CD3 (50 ng/ml), soluble anti-CD28 (50 ng/ml), IL-6 (50 ng/ml), TGF-beta (1 ng/ml), and IL-1 (10 ng/ml); Th17 cells were restimulated on day 5 (for cytokine expression) or not (for transcription factor expression) as in Figure 5C. Th1 and Th17 cells were cultured as in Figure, all in the absence (-; Control), with DMSO, or presence (+) of the PD184352 MEK inhibitor. Transcription factor expression is shown in (D). Similar results were obtained from three (A, B, and C) or two experiments (D, with two doses of inhibitor or control). Cytokine and transcription factor expression were analyzed from RNA isolated from all populations by RT real-time PCR.
###end p 134

